Progress in using circulating tumor cell information to improve metastatic breast cancer therapy

Journal of Oncology

Volumn , Issue , 2013, Pages

  Alemar, Jose ^a   Schuur, Eric R ^b,c  

^a Florida Cancer Specialists   (United States)

^b VMWA LLC   (United States)

^c The Jon Block Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BEVACIZUMAB; CA 15-3 ANTIGEN; CA 27-29 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORODEOXYGLUCOSE F 18; HISTONE H2AX; LACTATE DEHYDROGENASE;

BREAST CANCER; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER THERAPY; CELL ADHESION; CELL COUNT; CIRCULATING TUMOR CELL; CLINICAL DECISION MAKING; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EPITHELIUM CELL; HUMAN; MEDICAL INFORMATION; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 84876592595     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2013/702732     Document Type: Review

References (54)

1. Cancer Facts and Figures 2012 Atlanta, Ga, USA American Cancer Society
2. SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations). 2012, http://seer.cancer.gov/csr/1975-2009-pops09/
3. Langley R. R., Fidler I. J., The seed and soil hypothesis revisited: the role of tumor-stroma interactions in metastasis to different organs. International Journal of Cancer 2011 128 11 2527 2535 2-s2.0-79953300698 10.1002/ijc.26031
4. Ashworth T. R., A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Australian Medical Journal 1869 14 146 149
5. Rostagno P., Moll J. L., Bisconte J. C., Caldani C., Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model. Anticancer Research 1997 17 4 A 2481 2485 2-s2.0-0030742139 (Pubitemid 27352640)
6. Schoenfeld A., Kruger K. H., Gomm J., Sinnett H. D., Gazet J. C., Sacks N., Bender H. G., Luqmani Y., Coombes R. C., The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. European Journal of Cancer 1997 33 6 854 861 2-s2.0-0030842337 10.1016/S0959-8049(97)00014-2 (Pubitemid 27287035)
7. Pantel K., Cote R. J., Fodstad Ø., Detection and clinical importance of micrometastatic disease. Journal of the National Cancer Institute 1999 91 13 1113 1124 2-s2.0-0033532955 (Pubitemid 29330549)
8. Allard W. J., Matera J., Miller M. C., Repollet M., Connelly M. C., Rao C., Tibbe A. G. J., Uhr J. W., Terstappen L. W. M. M., Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research 2004 10 20 6897 6904 2-s2.0-6044259206 10.1158/1078-0432.CCR-04-0378 (Pubitemid 39383039)
9. Yu M., Stott S., Toner M., Maheswaran S., Haber D. A., Circulating tumor cells: approaches to isolation and characterization. Journal of Cell Biology 2011 192 3 373 382 2-s2.0-79551693066 10.1083/jcb.201010021
10. Riethdorf S., Fritsche H., Müller V., Rau T., Schindlbeck C., Rack B., Janni W., Coith C., Beck K., Jänicke F., Jackson S., Gornet T., Cristofanilli M., Pantel K., Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the cell search system. Clinical Cancer Research 2007 13 3 920 928 2-s2.0-33847402612 10.1158/1078-0432.CCR-06-1695 (Pubitemid 46340368)
11. Cristofanilli M., Budd G. T., Ellis M. J., Stopeck A., Matera J., Miller M. C., Reuben J. M., Doyle G. V., Allard W. J., Terstappen L. W. M. M., Hayes D. F., Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England Journal of Medicine 2004 351 8 781 791 2-s2.0-4143094988 10.1056/NEJMoa040766 (Pubitemid 39095313)
12. Cristofanilli M., Hayes D. F., Budd G. T., Ellis M. J., Stopeck A., Reuben J. M., Doyle G. V., Matera J., Allard W. J., Miller M. C., Fritsche H. A., Hortobagyi G. N., Terstappen L. W. M. M., Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. Journal of Clinical Oncology 2005 23 7 1420 1430 2-s2.0-20144385756 10.1200/JCO.2005.08.140
13. Hayes D. F., Cristofanilli M., Budd G. T., Ellis M. J., Stopeck A., Miller M. C., Matera J., Allard W. J., Doyle G. V., Terstappen L. W., Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clinical Cancer Research 2006 12 14 4218 4224 2-s2.0-33846814619 10.1158/1078-0432.CCR-05-2821
14. Budd G. T., Cristofanilli M., Ellis M. J., Stopeck A., Borden E., Miller M. C., Matera J., Repollet M., Doyle G. V., Terstappen L. W. M. M., Hayes D. F., Circulating tumor cells versus imaging: predicting overall survival in metastatic breast cancer. Clinical Cancer Research 2006 12 21 6403 6409 2-s2.0-33751272999 10.1158/1078-0432.CCR-05-1769 (Pubitemid 44799711)
15. Cohen S. J., Punt C. J. A., Iannotti N., Saidman B. H., Sabbath K. D., Gabrail N. Y., Picus J., Morse M., Mitchell E., Miller M. C., Doyle G. V., Tissing H., Terstappen L. W. M. M., Meropol N. J., Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Journal of Clinical Oncology 2008 26 19 3213 3221 2-s2.0-49249130844 10.1200/JCO.2007.15.8923
16. Danila D. C., Heller G., Gignac G. A., Gonzalez-Espinoza R., Anand A., Tanaka E., Lilja H., Schwartz L., Larson S., Fleisher M., Scher H. I., Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clinical Cancer Research 2007 13 23 7053 7058 2-s2.0-37249006715 10.1158/1078-0432.CCR-07-1506 (Pubitemid 350276887)
17. Krebs M. G., Sloane R., Priest L., Lancashire L., Hou J. M., Greystoke A., Ward T. H., Ferraldeschi R., Hughes A., Clack G., Ranson M., Dive C., Blackhall F. H., Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. Journal of Clinical Oncology 2011 29 12 1556 1563 2-s2.0-79955045007 10.1200/JCO.2010.28.7045
18. Beveridge R., Circulating tumor cells in the management of metastatic breast cancer patients. Community Oncology 2007 4 2 79 82 2-s2.0-34047162576 (Pubitemid 46524413)
19. Botteri E., Sandri M. T., Bagnardi V., Munzone E., Zorzino L., Rotmensz N., Casadio C., Cassatella M. C., Esposito A., Curigliano G., Salvatici M., Verri E., Adamoli L., Goldhirsch A., Nolè F., Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Research and Treatment 2010 122 1 211 217 2-s2.0-77953544034 10.1007/s10549-009-0668-7
20. Nakamura S., Yagata H., Ohno S., Yamaguchi H., Iwata H., Tsunoda N., Ito Y., Tokudome N., Toi M., Kuroi K., Suzuki E., Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer 2010 17 3 199 204 2-s2.0-77955514306 10.1007/s12282-009-0139-3
21. Pierga J.-Y., Hajage D., Delaloge S., Brain E., Campone M., Diéras V., Rolland E., Mignot L., Mathiot C., Bidard F.-C., High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Annals of Oncology 2012 23 3 618 624 10.1093/annonc/mdr263
22. Bidard F. C., Mathiot C., Degeorges A., Etienne-Grimaldi M. C., Delva R., Pivot X., Veyret C., Bergougnoux L., de Cremoux P., Milano G., Pierga J. Y., Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Annals of Oncology 2010 21 9 1765 1771 2-s2.0-77956132705 10.1093/annonc/mdq052
23. Bidard F.-C., Hajage D., Bachelot T., Delaloge S., Brain E., Campone M., Cottu P., Beuzeboc P., Rolland E., Mathiot C., Pierga J.-Y., Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study. Breast Cancer Research 2012 14 1 R29 10.1186/bcr3114
24. Giuliano M., Giordano A., Jackson S., Hess K. R., De Giorgi U., Mego M., Handy B. C., Ueno N. T., Alvarez R. H., De Laurentiis M., De Placido S., Valero V., Hortobagyi G. N., Reuben J. M., Cristofanilli M., Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Research 2011 13 3 R67 2-s2.0-79959468167 10.1186/bcr2907
25. Liu M. C., Shields P. G., Warren R. D., Cohen P., Wilkinson M., Ottaviano Y. L., Rao S. B., Eng-Wong J., Seillier-Moiseiwitsch F., Noone A. M., Isaacs C., Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. Journal of Clinical Oncology 2009 27 31 5153 5159 2-s2.0-70449713638 10.1200/JCO.2008.20.6664
26. Nolé F., Munzone E., Zorzino L., Minchella I., Salvatici M., Botteri E., Medici M., Verri E., Adamoli L., Rotmensz N., Goldhirsch A., Sandri M. T., Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Annals of Oncology 2008 19 5 891 897 2-s2.0-43049110616 10.1093/annonc/mdm558 (Pubitemid 351627303)
27. Tokudome N., Ito Y., Takahashi S., Kobayashi K., Taira S., Tsutsumi C., Oto M., Oba M., Inoue K., Kuwayama A., Masumura K., Nakayama Y., Watanabe C., Hatake K., Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients. Breast Cancer 2011 18 3 195 202 10.1007/s12282-011-0259-4
28. Yagata H., Nakamura S., Toi M., Bando H., Ohno S., Kataoka A., Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan. International Journal of Clinical Oncology 2008 13 3 252 256 2-s2.0-45749130612 10.1007/s10147-007-0748-9 (Pubitemid 351871893)
29. Consoli F., Grisanti S., Amoroso V., Almici C., Verardi R., Marini M., Simoncini E., Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial. Tumori 2011 97 6 737 742 10.1700/1018.11090
30. De Giorgi U., Valero V., Rohren E., Dawood S., Ueno N. T., Miller M. C., Doyle G. V., Jackson S., Andreopoulou E., Handy B. C., Reuben J. M., Fritsche H. A., Macapinlac H. A., Hortobagyi G. N., Cristofanilli M., Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. Journal of Clinical Oncology 2009 27 20 3303 3311 2-s2.0-70249150745 10.1200/JCO.2008.19. 4423
31. Hartkopf A. D., Wagner P., Wallwiener D., Fehm T., Rothmund R., Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer. Anticancer Research 2011 31 3 979 984 2-s2.0-79956136145
32. Graham M., Fleming N., Blumenthal S., Boehlke B., Schuur E., Circulating tumor cells (CTCs) and molecular subtypes (MST) in a treatment algorithm for metastatic breast cancer (MBC). ASCO Annual Meeting 2012 30 15, supplement e21022
33. Mego M., De Giorgi U., Dawood S., Wang X., Valero V., Andreopoulou E., Handy B., Ueno N. T., Reuben J. M., Cristofanilli M., Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. International journal of cancer 2011 129 2 417 423 2-s2.0-79961118743 10.1002/ijc.25690
34. Zhang L., Riethdorf S., Wu G., Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clinical Cancer Research 2012 19 20 5701 5710
35. Giordano A., Giuliano M., Arpino G., Jackson S., Handy B. C., Ueno N. T., Andreopoulou E., Alvarez R. H., Valero V., De placido S., Hortobagyi G. N., Reuben J. M., Cristofanilli M., Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy. Annals of Oncology 2012 23 5 1144 1150 10.1093/annonc/mdr434
36. Cristofanilli M., Broglio K. R., Guarneri V., Jackson S., Fritsche H. A., Islam R., Dawood S., Reuben J. M., Kau S. W., Lara J. M., Krishnamurthy S., Ueno N. T., Hortobagyi G. N., Valero V., Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clinical Breast Cancer 2007 7 6 471 479 2-s2.0-33947286218 10.3816/CBC.2007.n.004 (Pubitemid 46424284)
37. Rugo H. S., Jo Chien A., Franco S. X., Stopeck A. T., Glencer A., Lahiri S., Arbushites M. C., Scott J., Park J. W., Hudis C., Nulsen B., Dickler M. N., A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer. Breast Cancer Research and Treatment 2012 134 1 13 20 10.1007/s10549-011-1918-z
38. Carey L. A., Rugo H. S., Marcom P. K., Mayer E. L., Esteva F. J., Ma C. X., Liu M. C., Storniolo A. M., Rimawi M. F., Forero-Torres A., Wolff A. C., Hobday T. J., Ivanova A., Chiu W.-K., Ferraro M., Burrows E., Bernard P. S., Hoadley K. A., Perou C. M., Winer E. P., TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer. Journal of Clinical Oncology 2012 30 21 2615 2623 10.1200/JCO.2010.34. 5579
39. Dawood S., Broglio K., Valero V., Reuben J., Handy B., Islam R., Jackson S., Hortobagyi G. N., Fritsche H., Cristofanilli M., Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer 2008 113 9 2422 2430 2-s2.0-55549115023 10.1002/cncr.23852
40. Wallwiener M., Hartkopf A. D., Baccelli I., Riethdorf S., Schott S., Pantel K., Marmé F., Sohn C., Trumpp A., Rack B., Aktas B., Solomayer E.-F., Müller V., Janni W., Schneeweiss A., Fehm T. N., The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer. Breast Cancer Research and Treatment 2012 137 2 503 510 10.1007/s10549-012-2382- 0
41. Mego M., De Giorgi U., Hsu L., Ueno N. T., Valero V., Jackson S., Andreopoulou E., Kau S. W., Reuben J. M., Cristofanilli M., Circulating tumor cells in metastatic inflammatory breast cancer. Annals of Oncology 2009 20 11 1824 1828 2-s2.0-71049173176 10.1093/annonc/mdp207
42. De Giorgi U., Valero V., Rohren E., Mego M., Doyle G. V., Miller M. C., Ueno N. T., Handy B. C., Reuben J. M., Macapinlac H. A., Hortobagyi G. N., Cristofanilli M., Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Annals of Oncology 2009 21 1 33 39 2-s2.0-77949311998 10.1093/annonc/mdp262 mdp262
43. Saad A., Kanate A., Sehbai A., Marano G., Hobbs G., Abraham J., Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer. Clinical Breast Cancer 2008 8 4 357 361 2-s2.0-53449087876 10.3816/CBC.2008.n.042
44. Wang L. H., Pfister T. D., Parchment R. E., Kummar S., Rubinstein L., Evrard Y. A., Gutierrez M. E., Murgo A. J., Tomaszewski J. E., Doroshow J. H., Kinders R. J., Monitoring drug-induced γ H2AX as a pharmacodynamic biomarker in individual circulating tumor cells. Clinical Cancer Research 2010 16 3 1073 1084 2-s2.0-76049083071 10.1158/1078-0432.CCR-09-2799
45. Saad A., Abraham J., Role of tumor markers and circulating tumors cells in the management of breast cancer. Oncology 2008 22 7 726 731 2-s2.0-47549116585 (Pubitemid 352007333)
46. Bednarz-Knoll N., Alix-Panabieres C., Pantel K., Clinical relevance and biology of circulating tumor cells. Breast Cancer Research 2011 13 6, article 228
47. Liu Z., Fusi A., Schmittel A., Tinhofer I., Schneider A., Keilholz U., Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine. Cancer Biology and Therapy 2010 10 9 860 864 2-s2.0-78549294254 10.4161/cbt.10.9.13323
48. Coumans F. A. W., Ligthart S. T., Terstappen L. W., Interpretation of changes in circulating tumor cell counts. Translational Oncology 2012 5 6 486 491 10.1593/tlo.12247
49. Sherry M. M., Greco F. A., Johnson D. H., Hainsworth J. D., Metastatic breast cancer confined to the skeletal system: an indolent disease. The American Journal of Medicine 1986 81 3 381 386 2-s2.0-0022535311 (Pubitemid 16003855)
50. Budd G. T., Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Molecular Pharmaceutics 2009 6 5 1307 1310 2-s2.0-70350042015 10.1021/mp900088r
51. Hricak H., Oncologic imaging: a guiding hand of personalized cancer care. Radiology 2011 259 3 633 640 2-s2.0-79956294257 10.1148/radiol.11110252
52. Fehm T., Müller V., Aktas B., Janni W., Schneeweiss A., Stickeler E., Lattrich C., Löhberg C. R., Solomayer E., Rack B., Riethdorf S., Klein C., Schindlbeck C., Brocker K., Kasimir-Bauer S., Wallwiener D., Pantel K., HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Research and Treatment 2010 124 2 403 412 2-s2.0-78649327274 10.1007/s10549-010-1163-x
53. Hayashi N., Nakamura S., Tokuda Y., Shimoda Y., Yagata H., Yoshida A., Ota H., Hortobagyi G. N., Cristofanilli M., Ueno N. T., Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer. International Journal of Clinical Oncology 2012 17 2 96 104 2-s2.0-79958098585
54. Gazzaniga P., Naso G., Gradilone A., Cortesi E., Gandini O., Gianni W., Fabbri M. A., Vincenzi B., Di Silverio F., Frati L., Aglianò A. M., Cristofanilli M., Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors. International Journal of Cancer 2010 126 10 2437 2447 2-s2.0-77951233874 10.1002/ijc.24953